3,4-di-substituted cyclobutene1,2-diones as cxc-chemokine receptor ligands
Details for Australian Patent Application No. 2002311841 (hide)
International Classifications
Event Publications
2 January 2003 Complete Application Filed
Priority application(s): 60/284,026 16.04.01 US
17 April 2003 Application Open to Public Inspection
Published as AU-B-2002311841
11 November 2004 Assignment before Grant
Schering Corporation; Pharmacopeia, Inc. The application has been assigned to Schering Corporation; Pharmacopeia Drug Discovery, Inc.
14 September 2006 Application Accepted
Published as AU-B-2002311841
18 January 2007 Standard Patent Sealed
13 September 2007 Assignment Registered
Pharmacopeia Drug Discovery, Inc.; Schering Corporation The patent has been assigned to Pharmacopeia, Inc.; Schering Corporation
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002311840-NUCLEIC ACIDS THAT CONTROL REPRODUCTIVE DEVELOPMENT IN PLANTS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser